Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
The term "Serine-threonine stemness kinase" describes a serine/threonine-specific protein kinase (STK) that plays a role in maintaining cellular stemness or pluripotency. These kinases regulate diverse cellular processes including signal transduction, cell cycle progression, metabolism, proliferation, differentiation, and survival. Key families include Akt/PKB, MAPK/ERK, PAK1 and CK1. Due to their involvement in stem cell maintenance and cancer, they are considered major drug targets.
Phosphorylation of serine and threonine residues on target proteins, leading to changes in protein activity, localization, protein-protein interactions, and stability.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on Serine-Threonine Stemness Kinase.